-
Article
Open AccessCost-effectiveness of a multidimensional post-discharge disease management program for heart failure patients—economic evaluation along a one-year observation period
This study aimed to assess the cost-effectiveness of the telemedically assisted post-discharge management program (DMP) HerzMobil Tirol (HMT) for heart failure (HF) patients in clinical practice in Austria.
-
Article
Feasibility and effectiveness of a multidimensional post-discharge disease management programme for heart failure patients in clinical practice: the HerzMobil Tirol programme
It remains unclear whether transitional care management outside of a clinical trial setting provides benefits for patients with acute heart failure (AHF) after hospitalization. We evaluated the feasibility and...
-
Article
Open AccessWhen and how do patients with cardiac amyloidosis die?
Cardiac amyloidosis (CA) is an underappreciated cause of morbidity and mortality. Light-chain (AL) and transthyretin (ATTR) amyloidosis have different disease trajectories. No data are available on subtype-spe...
-
Article
Open AccessKlotho is upregulated in human cardiomyopathy independently of circulating Klotho levels
Klotho is an antiaging protein which exerts known cardioprotection. In kidney, trans-membrane Klotho acts as essential co-receptor of fibroblast growth factor 23 (FGF23). In the heart, soluble Klotho (sKlotho)...
-
Article
Long-term outcome of cytomegalovirus high-risk patients after heart transplantation: comparison between two prophylactic regimes – a single-center experience
BACKGROUND: Implantation of a cytomegalovirus (CMV)-positive graft (D+) into a CMV-negative recipient (R–) is a high-risk constellation after heart transplantation (HTX). CMV infection after HTX is associated ...
